These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32625270)

  • 1. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 2).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Heng L; Valtueña Martínez S; Siani A
    EFSA J; 2017 Jan; 15(1):e04680. PubMed ID: 32625270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 3).
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06554. PubMed ID: 33791038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General scientific guidance for stakeholders on health claim applications (Revision 1).
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06553. PubMed ID: 33791037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidance on the scientific requirements for health claims related to muscle function and physical performance: (Revision 1).
    ; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Thies F; Tsabouri S; Vinceti M; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Neuhäuser-Berthold M; Nowicka G; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Willatts P; Martin A; Strain JJ; Heng L; Valtueña Martínez S; Siani A
    EFSA J; 2018 Oct; 16(10):e05434. PubMed ID: 32625715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidance on the preparation and presentation of applications for exemption from mandatory labelling of food allergens and/or products thereof pursuant to Article 21 (2) of Regulation (EU) No 1169/2011.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06543. PubMed ID: 33791035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidance for the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health: (Revision 1).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Heng L; Valtueña Martínez S; Siani A
    EFSA J; 2018 Jan; 16(1):e05136. PubMed ID: 32625682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow-on formula manufactured from protein hydrolysates.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Fewtrell M; Przyrembel H; Titz A; Valtueña Martínez S
    EFSA J; 2017 May; 15(5):e04779. PubMed ID: 32625485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific and technical guidance on foods for special medical purposes in the context of Article 3 of Regulation (EU) No 609/2013.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06544. PubMed ID: 33791036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scientific substantiation of health claims in the EU.
    Flynn A
    Proc Nutr Soc; 2012 Feb; 71(1):120-6. PubMed ID: 21933455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vibigaba (germinated brown rice) and reduction of body weight in the context of an energy-restricted diet: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Siani A
    EFSA J; 2017 Jul; 15(7):e04915. PubMed ID: 32625575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vibigaba (germinated brown rice) and maintenance of long-term normal blood glucose concentration: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Siani A
    EFSA J; 2017 Jul; 15(7):e04916. PubMed ID: 32625576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vibigaba (germinated brown rice) and maintenance of normal blood pressure: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Siani A
    EFSA J; 2017 Jul; 15(7):e04914. PubMed ID: 32625574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vibigaba (germinated brown rice) and maintenance of normal blood cholesterol concentration: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Siani A
    EFSA J; 2017 Jul; 15(7):e04913. PubMed ID: 32625573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthohumol in XERME
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain SJ; Siani A
    EFSA J; 2018 Mar; 16(3):e05192. PubMed ID: 32625830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NWT-02, a fixed combination of lutein, zeaxanthin and docosahexaenoic acid in egg yolk and reduction of the loss of vision: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain SJJ; Siani A
    EFSA J; 2018 Jan; 16(1):e05139. PubMed ID: 32625685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidance on the preparation and submission of the notification and application for authorisation of traditional foods from third countries in the context of Regulation (EU) 2015/2283 (Revision 1).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Schlatter J; Gelbmann W; de Sesmaisons-Lecarré A; Verhagen H; van Loveren H
    EFSA J; 2021 Mar; 19(3):e06557. PubMed ID: 33791041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stablor
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Siani A
    EFSA J; 2017 Feb; 15(2):e04723. PubMed ID: 32625415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin and normal functioning of joints: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Siani A
    EFSA J; 2017 May; 15(5):e04774. PubMed ID: 32625480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics.
    Binnendijk KH; Rijkers GT
    Benef Microbes; 2013 Sep; 4(3):223-30. PubMed ID: 23685375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-carnitine and contribution to normal lipid metabolism: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain SJJ; Siani A
    EFSA J; 2018 Jan; 16(1):e05137. PubMed ID: 32625683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.